HeraMED Limited
ASX: HMD.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Anoushka Gungadin
- Headquarters
- Netanya, Israel
- IPO year
- 2018
- Market cap
- A$34.0M
- Website
- https://www.hera-med.com
Loading HMD…
Loading profile data…Frequently asked questions about HMD
What does HeraMED Limited (HMD.AX) do?
HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. The company provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus' heartbeat; and HeraCARE, a digital pregn...
Where does HMD.AX trade?
HeraMED Limited (HMD.AX) trades on the Australian Securities Exchange.
What sector is HMD.AX in?
HeraMED Limited (HMD.AX) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of HeraMED Limited?
Anoushka Gungadin is the chief executive officer of HeraMED Limited (HMD.AX).
Where is HeraMED Limited headquartered?
HeraMED Limited is headquartered in Israel.
Does HMD.AX pay a dividend?
HeraMED Limited (HMD.AX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HMD.AX go public?
HeraMED Limited (HMD.AX) completed its initial public offering in 2018.